title: Risk of potentially life-threatening thyroid dysfunction due to amiodarone in idiopathic pulmonary arterial hypertension patients.
authors.forename: Elaine
authors.initials: E
authors.lastname: Soon
authors.forename: Mark
authors.initials: M
authors.lastname: Toshner
authors.forename: Marianna
authors.initials: M
authors.lastname: Mela
authors.forename: Andrew
authors.initials: A
authors.lastname: Grace
authors.forename: Karen
authors.initials: K
authors.lastname: Sheares
authors.forename: Nicholas
authors.initials: N
authors.lastname: Morrell
authors.forename: Joanna
authors.initials: J
authors.lastname: Pepke-Zaba
mesh_terms: D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy*; D006980:Hyperthyroidism / Q000139:chemically induced* / Q000401:mortality* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012016:Reference Values; D012189:Retrospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate; D013960:Thyroid Function Tests; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014665:Vasodilator Agents; D000638:Amiodarone